Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
274.04
377.53
340.65
260.02
210.27
138.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
274.04
377.53
340.65
260.02
210.27
138.21
Raw Material Cost
212.74
238.06
180.17
132.22
102.14
63.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
63.57
76.74
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.02
0.03
0.02
0.02
0.02
0.01
Selling and Distribution Expenses
31.41
31.78
26.83
18.00
16.01
11.60
Other Expenses
-3.61
-2.13
3.14
1.44
0.91
0.64
Total Expenditure (Excl Depreciation)
271.66
325.30
238.37
164.63
127.28
81.70
Operating Profit (PBDIT) excl Other Income
2.4
52.199999999999996
102.30000000000001
95.39999999999999
83
56.5
Other Income
15.98
32.28
12.96
14.76
10.86
6.06
Operating Profit (PBDIT)
36.30
101.08
128.28
118.48
100.05
67.07
Interest
0.02
0.03
0.02
0.02
0.02
0.01
Exceptional Items
18.98
7.03
3.77
0.00
-0.00
-0.07
Gross Profit (PBDT)
61.30
139.47
160.48
127.80
108.13
74.53
Depreciation
19.41
18.59
12.39
7.32
5.71
4.24
Profit Before Tax
35.85
89.50
119.64
111.15
94.33
62.75
Tax
-0.58
3.97
11.55
12.41
12.46
8.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.43
85.53
108.09
98.73
81.87
54.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.43
85.53
108.09
98.73
81.87
54.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
36.43
85.53
108.09
98.73
81.87
54.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
Reserves
1,515.40
1,513.37
1,464.01
331.62
232.88
151.01
Earnings per share (EPS)
0.55
1.28
1.62
1.48
1.23
0.82
Diluted Earnings per share
0.55
1.28
1.62
1.48
1.23
0.82
Operating Profit Margin (Excl OI)
0.33%
13.3%
30.22%
37.08%
39.71%
41.08%
Gross Profit Margin
20.17%
28.63%
38.76%
45.56%
47.57%
48.47%
PAT Margin
13.3%
22.66%
31.73%
37.97%
38.94%
39.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -27.42% vs 10.83% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -57.43% vs -20.91% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -70.49% vs -40.33% in Dec 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Anhui Wanbang Pharmaceutical Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
274.04
0
274.04
Other Operating Income
0.00
0.00
0.00
Total Operating income
274.04
0
274.04
Raw Material Cost
212.74
0
212.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
63.57
0
63.57
Power Cost
0
0
0.00
Manufacturing Expenses
0.02
0
0.02
Selling and Distribution Expenses
31.41
0
31.41
Other Expenses
-3.61
0.00
-3.61
Total Expenditure (Excl Depreciation)
271.66
0
271.66
Operating Profit (PBDIT) excl Other Income
2.38
0.00
2.38
Other Income
15.98
0
15.98
Operating Profit (PBDIT)
36.30
0
36.30
Interest
0.02
0
0.02
Exceptional Items
18.98
0
18.98
Gross Profit (PBDT)
61.30
0
61.30
Depreciation
19.41
0
19.41
Profit Before Tax
35.85
0
35.85
Tax
-0.58
0
-0.58
Provisions and contingencies
0
0
0.00
Profit After Tax
36.43
0
36.43
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
36.43
0
36.43
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
36.43
0
36.43
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,515.40
0
1,515.40
Earnings per share (EPS)
0.55
0
0.55
Diluted Earnings per share
0.55
0
0.55
Operating Profit Margin (Excl OI)
0.33%
0%
0.00
0.33%
Gross Profit Margin
20.17%
0%
0.00
20.17%
PAT Margin
13.30%
0%
0.00
13.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 27.40 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -27.42% vs 10.83% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3.64 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -57.43% vs -20.91% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.03 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -70.49% vs -40.33% in Dec 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.33%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






